“What we need is competition in the marketplace and all things medical,” says Dr. Harvey Risch, professor emeritus of epidemiology at the Yale School of Public Health and Yale School of Medicine. Three years since the start of the pandemic, we discuss what we know now about COVID-19, mask efficacy, vaccine harms, and treatment protocols….

“What we need is competition in the marketplace and all things medical,” says Dr. Harvey Risch, professor emeritus of epidemiology at the Yale School of Public Health and Yale School of Medicine. Three years since the start of the pandemic, we discuss what we know now about COVID-19, mask efficacy, vaccine harms, and treatment protocols….

“What we need is competition in the marketplace and all things medical,” says Dr. Harvey Risch, professor emeritus of epidemiology at the Yale School of Public Health and Yale School of Medicine. Three years since the start of the pandemic, we discuss what we know now about COVID-19, mask efficacy, vaccine harms, and treatment protocols….

“What we need is competition in the marketplace and all things medical,” says Dr. Harvey Risch, professor emeritus of epidemiology at the Yale School of Public Health and Yale School of Medicine. Three years since the start of the pandemic, we discuss what we know now about COVID-19, mask efficacy, vaccine harms, and treatment protocols….

Dr. Anthony Fauci is claiming that there was not enough time to wait for clinical trial data before clearing updated COVID-19 booster shots. “We don’t have time to do a clinical trial because we need to get the vaccine out now,” Fauci said on CBC this week, pointing to how about 400 Americans are dying…

This episode will premiere on Saturday, July 16, at 7:30 p.m. ET.  “The vaccines have done damage to the immune system such that it makes people more likely to get COVID—over a longer term, not the short-term vaccine benefit period, but after that—more likely to get COVID infections, more likely to get other respiratory infections.”…

“The vaccines have done damage to the immune system such that it makes people more likely to get COVID—over a longer term, not the short-term vaccine benefit period, but after that—more likely to get COVID infections, more likely to get other respiratory infections.” I sit down with Dr. Harvey Risch, professor emeritus of epidemiology at…

“These drugs have been suppressed… for reasons that have nothing to do with the science and the medicine.” In this episode, we sit down with Dr. Harvey Risch, a professor of epidemiology at the Yale School of Public Health and Yale School of Medicine. He says therapeutics, including hydroxychloroquine and ivermectin, can be highly effective…